Edition:
United Kingdom

Arcturus Therapeutics Ltd (ARCT.OQ)

ARCT.OQ on NASDAQ Stock Exchange Global Market

6.41USD
21 May 2019
Change (% chg)

$0.26 (+4.23%)
Prev Close
$6.15
Open
$6.19
Day's High
$6.50
Day's Low
$6.19
Volume
3,026
Avg. Vol
12,768
52-wk High
$10.00
52-wk Low
$4.11

About

Arcturus Therapeutics Ltd. is a ribonucleic acid (RNA) medicines company. The Company owns Lipid-enabled and Unlocked Nucleomonomer Agent modified RNA (LUNAR) lipid-mediated delivery and Unlocked Nucleomonomer Agent (UNA) technology, including UNA Oligomers. The Company’s diverse pipeline of RNA therapeutics includes programs... (more)

Overall

Beta: 2.25
Market Cap(Mil.): $66.18
Shares Outstanding(Mil.): 10.76
Dividend: --
Yield (%): --

Financials

  ARCT.OQ Industry Sector
P/E (TTM): -- 97.03 53.45
EPS (TTM): -2.19 -- --
ROI: -- 7.44 11.71
ROE: -- 7.90 16.35

Earnings vs. Estimates